ID   OPM-3
AC   CVCL_M529
DR   Wikidata; Q54936485
RX   PubMed=9858236;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=9858236; DOI=10.1046/j.1365-2141.1998.01049.x;
RA   Yoshida H., Nishiura T., Karasuno T., Matsumura I., Ishikawa J.,
RA   Yoshimura M., Yokota T., Okajima Y., Ogawa M., Kanakura Y.,
RA   Tomiyama Y., Matsuzawa Y.;
RT   "Effect of the interaction between fibronectin and VLA-4 on the
RT   proliferation of human B cells, especially a novel human B-cell line,
RT   OPM-3.";
RL   Br. J. Haematol. 103:804-812(1998).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//